|
Sex (male, female)
|
0.4
|
1.35
|
(0.655, 2.043)
|
|
Age (≤50 or younger,>50)
|
0.13
|
2.49
|
(1.300, 3.680)
|
|
Tumor location Post1
|
0.75
|
1.16
|
(0.244, 2.082)
|
|
Tumor location Post2
|
0. 448
|
1.38
|
(0.551, 2.201)
|
|
Tumor location Post3
|
0.98
|
0
|
(−1242.048, 1242.048)
|
|
Tumor location Post4
|
0.99
|
0
|
(−1596.148, 1596.148)
|
|
Tumor location Post5
|
0.77
|
0.8
|
(−0.692, 2.288)
|
|
Tumor size (T1-T4)
|
0.45
|
1.18
|
(0.757, 1.595)
|
|
Nodal metastasis (N0, N(+))
|
0.44
|
1.31
|
(0.618, 2.006)
|
|
Metastasis (M0, M(+))
|
0.69
|
0.05
|
(0.760, 1.470)
|
|
Clinical stage (I, II, III, IV)
|
0.55
|
1.12
|
(1.146, 2.200)
|
|
Pathological grade
|
0.06
|
1.67
|
(0.244, 2.082)
|
|
CD68+ macrophages counts in tumor nest (Low, High)
|
0.01
|
3.08
|
(2.236, 3.914)
|
|
CD68+ macrophages counts in tumor stroma (Low, High)
|
0.3
|
0.69
|
(−0.010, 1.390)
|
|
CD163+ macrophages counts in tumor nest (Low, High)
|
0.02
|
2.83
|
(1.991, 3.669)
|
|
CD163+ macrophages counts in tumor stroma (Low, High)
|
0.48
|
0.78
|
(0.085, 1.473)
|
|
CD68 expression in tumor (Negative, Low, High)
|
0.97
|
1.01
|
(0.555, 1.465)
|
|
CD163 expression in tumor (Negative, Low, High)
|
0
|
2.2
|
(1.735, 2.667)
|
|
E-cadherin expression in tumor (Negative, Low, High)
|
0.61
|
0.89
|
(0.465, 1.323)
|
|
E-cadherin expression at the invasive front of tumor (Negative, Low, High)
|
0.19
|
0.74
|
(0.280, 1.1937)
|
|
Vimentin expression in tumor (Negative, Low, High)
|
0.01
|
1.79
|
(1.373, 2.207)
|
|
Vimentin expression at the invasive front of tumor (Negative, Low, High)
|
0
|
1.88
|
(1.474, 2.295)
|
